ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 372155 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 372155; 2) Community: the network communities that were significantly associated with the response to NSC 372155; 3) Molecule: the relationships between components within communities and NSC 372155; 4) MDR: the compounds that were significantly associated with the NSC 372155.

NSC Compound Enrichment Correlation
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0297837393005856 0.47213567
NSC 244404 Null 0.0297837393005856 0.15922685
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0297837393005856 0.34874076
NSC 300289 Pinafide 0.0297837393005856 0.16544981
NSC 303861 L-Cysteine analog 0.0297837393005856 0.46509995
NSC 339137 PHYSALOLACTONE 0.0297837393005856 0.42100697
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0297837393005856 0.10181018
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0297837393005856 0.11141449
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0297837393005856 0.13037183
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0297837393005856 0.28126302
Total:199  Current:147    [First] [Prev] [Next] [Last]